Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jun 24:11:146.
doi: 10.3389/fnagi.2019.00146. eCollection 2019.

Modifiable Risk Factors for Alzheimer's Disease

George A Edwards Iii  1 , Nazaret Gamez  1   2 , Gabriel Escobedo Jr  1 , Olivia Calderon  1 , Ines Moreno-Gonzalez  1   2
Affiliations

Modifiable Risk Factors for Alzheimer's Disease

George A Edwards Iii et al. Front Aging Neurosci. .

Abstract

Since first described in the early 1900s, Alzheimer's disease (AD) has risen exponentially in prevalence and concern. Research still drives to understand the etiology and pathogenesis of this disease and what risk factors can attribute to AD. With a majority of AD cases being of sporadic origin, the increasing exponential growth of an aged population and a lack of treatment, it is imperative to discover an easy accessible preventative method for AD. Some risk factors can increase the propensity of AD such as aging, sex, and genetics. Moreover, there are also modifiable risk factors-in terms of treatable medical conditions and lifestyle choices-that play a role in developing AD. These risk factors have their own biological mechanisms that may contribute to AD etiology and pathological consequences. In this review article, we will discuss modifiable risk factors and discuss the current literature of how each of these factors interplay into AD development and progression and if strategically analyzed and treated, could aid in protection against this neurodegenerative disease.

Keywords: Alzheimer’s disease; comorbidities; depression; epilepsy; lifestyle; risk factors; traumatic brain injury; vascular disease.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Abdullah L., Evans J. E., Emmerich T., Crynen G., Shackleton B., Keegan A. P., et al. . (2017). APOE ε4 specific imbalance of arachidonic acid and docosahexaenoic acid in serum phospholipids identifies individuals with preclinical mild cognitive impairment/Alzheimer’s disease. Aging 9, 964–985. 10.18632/aging.101203 - DOI - PMC - PubMed
    1. Abedini A., Schmidt A. M., States U. (2015). Mechanisms of islet amyloidosis toxicity in type 2 diabetes. FEBS Lett. 587, 1119–1127. 10.1016/j.febslet.2013.01.017 - DOI - PMC - PubMed
    1. Abner E. L., Nelson P. T., Jicha G. A., Fardo D. W., Schmitt F. A., Kryscio R. J. (2018). Cigarette smoking and risk of dementia in a Kentucky cohort: a competing risk analysis. Alzheimers Dement. 14:973 10.1016/j.jalz.2018.06.1306 - DOI - PMC - PubMed
    1. Adlard P. A., Perreau V. M., Pop V., Cotman C. W. (2005). Voluntary exercise decreases amyloid load in a transgenic model of Alzheimer’s disease. J. Neurosci. 25, 4217–4221. 10.1523/JNEUROSCI.0496-05.2005 - DOI - PMC - PubMed
    1. Air E. L., Kissela B. M. (2007). Diabetes, the metabolic syndrome, and ischemic stroke: epidemiology and possible mechanisms. Diabetes Care 30, 3131–3140. 10.2337/dc06-1537 - DOI - PubMed

LinkOut - more resources